MedTrace Logo

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

NCT01004523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2016-07-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This research study is looking at tissue and blood samples from patients with low-grade glioma.

Conditions

Interventions

GENETIC

fluorescence in situ hybridization

GENETIC

loss of heterozygosity analysis

GENETIC

polymerase chain reaction

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Jan Buckner, MD · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-12-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01004523 on ClinicalTrials.gov